Intersouth Partners Names Katrin Burt and James Rosen Partners

DURHAM, N.C.--(BUSINESS WIRE)--Intersouth Partners, a venture capital firm focused on helping visionary entrepreneurs build high-impact companies by providing early stage capital, announced today that Katrin Burt and James Rosen have been named partners at the firm.

“Jimmy and Katrin have been an integral part of the Intersouth team since joining the firm in 2005”

Burt has been an associate of the firm since 2007 as a member of the technology team. She joined Intersouth in 2004 as an analyst, working with the firm’s investment team on the analysis of potential new investments and the growth of Intersouth’s existing portfolio companies. She joined Intersouth from HSBC, where she was a foreign exchange trader in London, managed portfolios of treasury products and equities in Tokyo and eventually moved to a business development role managing the annual operating plan for the bank’s Global Markets Europe Division. She received a B.A. from Oxford University, an M.B.A. from Duke University’s Fuqua School of Business and an M.S. in Microsystems and Nanotechnology from Cranfield University.

Burt works with Intersouth’s technology portfolio, including portfolio companies HexaTech, siXis, Bright Hub and Ziptronix.

Rosen has been an associate of the firm since 2007 as a member of the life sciences team. He joined Intersouth as an investment intern in 2005 while completing his graduate degrees. Prior to graduate school, he worked at the UNC Lineberger Comprehensive Cancer Center. He was an equity research analyst at Brean Murray & Co., covering biopharmaceuticals, genomics, generics, drug delivery and medical device companies. He has also worked in clinical research at multiple institutions and completed projects for the National Cancer Institute. He spent five years in Emergency Medical Services as a mountain search and rescue and ambulance medic. Rosen received a B.A. from Duke University, an M.B.A. from UNC’s Kenan-Flagler Business School and an M.S.P.H. from the UNC School of Public Health.

Rosen works with Intersouth’s life science companies, including ABT Molecular Imaging, Applied Genetic Technologies Corporation (AGTC), Cempra Pharmaceuticals and Viamet Pharmaceuticals.

“Jimmy and Katrin have been an integral part of the Intersouth team since joining the firm in 2005,” said Intersouth managing partner Dennis Dougherty. “Entrepreneurs within the community rely on them as trusted advisors with a strong work ethic and the highest integrity. As partners, they will continue to seek out the strongest management teams and the most exciting start-up opportunities for Intersouth to partner with and support.”

As partners, Burt and Rosen will continue to source investments, perform due diligence and manage portfolio companies. Intersouth has twelve investment professionals on its team, covering both life science and technology investments for the firm.

About Intersouth Partners

Located in Durham, North Carolina, Intersouth Partners is one of the largest, most active and most experienced early stage venture funds in the country, having invested in more than 100 private companies over the last two decades. Founded in 1985, Intersouth Partners manages $780 million in seven venture capital limited partnerships. Intersouth seeks a broad range of seed and early-stage investment opportunities throughout the Southeast, focusing on the technology and life sciences sectors. Visit www.intersouth.com for more information.